iMFLUX, a wholly owned subsidiary of Procter & Gamble, is transforming the future of plastic injection molding.
With iMFLUX, sites run more reliably with fewer operator adjustments.
Manufacturers can produce higher quality parts, reduce costs, and lower capital – all while advancing sustainability efforts.
iMFLUX provides the way to autonomous molding with a new capability to design and mold that impossible part. The revolutionary low-constant-pressure injection molding platform works with virtually any plastic injection machine, material, and mold.
For specific questions or more information, please email us.